STRS Ohio’s Tarsus Pharmaceuticals TARS Stock Holding History

STRS Ohio’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	17,300 +8,500	+97%	+$543K	﹤0.01%	699
2026 Q1	$617K	Buy	8,800 +400	+5%	+$27.9K	﹤0.01%	931
2025 Q4	$688K	Sell	8,400 -2,100	-20%	-$157K	﹤0.01%	848
2025 Q3	$624K	Sell	10,500 -8,000	-43%	-$394K	﹤0.01%	908
2025 Q2	$749K	Buy	18,500 +12,900	+230%	+$581K	﹤0.01%	1028
2025 Q1	$288K	Buy	5,600 +400	+8%	+$19.8K	﹤0.01%	1416
2024 Q4	$288K	Buy	+5,200	New	+$236K	﹤0.01%	1393
2023 Q2	–	Sell	-3,800	Closed	-$47K	–	2093
2023 Q1	$47K	Sell	3,800 -19,300	-84%	-$282K	﹤0.01%	1794
2022 Q4	$338K	Sell	23,100 -4,900	-18%	-$81.1K	﹤0.01%	1463
2022 Q3	$479K	Hold	28,000	–	–	﹤0.01%	1347
2022 Q2	$408K	Buy	28,000 +25,900	+1,233%	+$389K	﹤0.01%	1413
2022 Q1	$35K	Hold	2,100	–	–	﹤0.01%	1989
2021 Q4	$47K	Hold	2,100	–	–	﹤0.01%	2010
2021 Q3	$45K	Hold	2,100	–	–	﹤0.01%	2086
2021 Q2	$60K	Buy	2,100 +600	+40%	+$18.7K	﹤0.01%	2076
2021 Q1	$48K	Hold	1,500	–	–	﹤0.01%	2033
2020 Q4	$61K	Buy	+1,500	New	+$42.7K	﹤0.01%	1972

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

STRS Ohio's TARS Position: Q2 2026 in Review

STRS Ohio increased its Tarsus Pharmaceuticals (TARS) stake by 97% in Q2 2026, buying an estimated $543K and bringing the position to 17,300 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #699.

STRS Ohio first reported a position in TARS in Q4 2020 and has held it in 17 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

STRS Ohio held 17,300 shares of Tarsus Pharmaceuticals worth $1.09M as of Q2 2026.
STRS Ohio bought 8,500 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $543K.
Tarsus Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #699 holding.
STRS Ohio first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.